Skip to content

Gilead, Merck, BMS plan fixed dose combination

FTC price agreement will allow first-line use in London

Prednisolone delays CD4 T-cell decreases in chronic HIV infection

Can a sugar cane drink effectively treat mitochondrial toxicity?

Prodrug of tenofovir works well in the presence of some NRTI resistance

Canadian company reports promising lipodystrophy treatment

Four year follow-up shows Kaletra to be safe, effective, durable

New-Fill recommended for approval in US as Sculptra (amended)

HIV-specific immune responses key to speed of disease progression